GetTopicDetailResponse(id=1e4212343378, topicName=Talquetamab, introduction=, content=多發(fā)性骨髓瘤 Talquetamab, image=null, comments=0, allHits=315, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Sat Jan 18 17:15:33 CST 2025, time=2025-01-18, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=467732, tagList=[TagDto(tagId=467732, tagName=Talquetamab)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2248624, encodeId=4e6b224862498, content=<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多發(fā)性骨髓瘤#</a> <a href='/topic/show?id=1e4212343378' target=_blank style='color:#2F92EE;'>#Talquetamab#</a>, objectTitle=NEJM：雙特異性抗體治療多發(fā)性骨髓瘤再獲突破，18個月持續(xù)反應率達86%！, objectType=article, longId=859985, objectId=e7318599854a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250114/1736819841908_8538692.jpg, objectUrl=/article/show_article.do?id=e7318599854a, replyNumber=0, likeNumber=37, createdTime=2025-01-18, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e7318599854a, moduleTitle=NEJM：雙特異性抗體治療多發(fā)性骨髓瘤再獲突破，18個月持續(xù)反應率達86%！, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=e7318599854a)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-01-18發(fā)表于上海
